» Articles » PMID: 5767308

Human Hypoxanthine Phosphoribosyltransferase. I. Purification, Properties, and Specificity

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1969 Mar 10
PMID 5767308
Citations 36
Authors
Affiliations
Soon will be listed here.
Citing Articles

Preclinical Demonstration of a Novel Treatment with High Efficacy and No Detectable Toxicity for Inflammatory Skin Conditions including Psoriasis.

Vanden Heuvel J, Zhou S, Patel A, Kamerow H, Baran P, Ford J Biomed Res Int. 2023; 2023:4878774.

PMID: 37469991 PMC: 10353900. DOI: 10.1155/2023/4878774.


Systemic host inflammation induces stage-specific transcriptomic modification and slower maturation in malaria parasites.

Lansink L, Skinner O, Engel J, Lee H, Soon M, Williams C mBio. 2023; 14(4):e0112923.

PMID: 37449844 PMC: 10470790. DOI: 10.1128/mbio.01129-23.


Pharmacogenetics of thiopurines.

Franca R, Zudeh G, Pagarin S, Rabusin M, Lucafo M, Stocco G Cancer Drug Resist. 2022; 2(2):256-270.

PMID: 35582727 PMC: 8992634. DOI: 10.20517/cdr.2019.004.


Perfecting a high hypoxanthine phosphoribosyltransferase activity-uricase KO mice to test the effects of purine- and non-purine-type xanthine dehydrogenase (XDH) inhibitors.

Hosoya T, Uchida S, Shibata S, Tomioka N, Hosoyamada M Br J Pharmacol. 2020; 177(10):2274-2285.

PMID: 31971609 PMC: 7174878. DOI: 10.1111/bph.14978.


Febuxostat, a Xanthine Oxidoreductase Inhibitor, Decreases NLRP3-dependent Inflammation in Macrophages by Activating the Purine Salvage Pathway and Restoring Cellular Bioenergetics.

Nomura J, Kobayashi T, So A, Busso N Sci Rep. 2019; 9(1):17314.

PMID: 31754153 PMC: 6872548. DOI: 10.1038/s41598-019-53965-x.